Maternal care for anti-D [Rh] antibodies, unspecified trimester (not applicable or unspecified)
ICD-10 O36.0190 is a billable code used to indicate a diagnosis of maternal care for anti-d [rh] antibodies, unspecified trimester (not applicable or unspecified).
Maternal care for anti-D [Rh] antibodies refers to the management and monitoring of pregnant women who have developed antibodies against the Rh factor, which can lead to hemolytic disease of the newborn (HDN). This condition arises when an Rh-negative mother carries an Rh-positive fetus, leading to potential complications such as fetal anemia, hydrops fetalis, and intrauterine growth restriction (IUGR). The unspecified trimester designation indicates that the timing of the maternal care is not clearly defined, which can complicate management strategies. Clinicians must closely monitor fetal growth and well-being through ultrasound assessments and non-stress tests to detect any signs of fetal distress or growth restriction. The management may include administering Rh immunoglobulin (RhoGAM) to prevent antibody formation in future pregnancies and ensuring appropriate follow-up care to monitor fetal health throughout the pregnancy.
Documentation must include maternal blood type, antibody screening results, and details of fetal monitoring.
Management of an Rh-negative mother with a known Rh-positive partner, monitoring for fetal anemia.
Accurate coding requires clear documentation of the trimester and any interventions performed.
Detailed records of high-risk assessments, including ultrasound findings and fetal heart rate monitoring.
Complex cases involving fetal growth restriction due to Rh incompatibility.
High-risk pregnancies necessitate comprehensive documentation of all interventions and outcomes.
Used for comprehensive obstetric care in patients with anti-D antibodies.
Complete documentation of all prenatal visits and interventions.
Obstetricians must ensure thorough records of maternal and fetal assessments.
Coding O36.0190 is crucial for tracking maternal health conditions related to Rh incompatibility, ensuring appropriate care and monitoring for potential fetal complications.
